Scarica l'app Stockscreener
3.01
1.01%
0.03
Dopo l'orario di chiusura:
3.02
0.01
+0.33%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.98
Aprire:
$3.02
Volume 24 ore:
348.29K
Relative Volume:
0.61
Capitalizzazione di mercato:
$215.92M
Reddito:
$405.47M
Utile/perdita netta:
$53.66M
Rapporto P/E:
4.1806
EPS:
0.72
Flusso di cassa netto:
$131.28M
1 W Prestazione:
+7.50%
1M Prestazione:
+3.79%
6M Prestazione:
-4.44%
1 anno Prestazione:
-10.68%
Intervallo 1D:
$2.96
$3.08
Intervallo di 1 settimana:
$2.51
$3.2154
Portata 52W:
$2.08
$4.22
Orasure Technologies Inc Stock (OSUR) Company Profile
Nome
Orasure Technologies Inc
Settore
Industria
Telefono
(503) 641-6115
Indirizzo
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
3.01 | 213.77M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
501.18 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.49 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.27 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.05 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
42.88 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-03 | Ripresa | Evercore ISI | In-line |
| 2021-09-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Iniziato | Evercore ISI | Outperform |
| 2020-08-10 | Iniziato | Citigroup | Buy |
| 2020-08-10 | Iniziato | JP Morgan | Neutral |
| 2020-08-07 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Iniziato | Lake Street | Buy |
| 2020-04-21 | Ripresa | Stephens | Equal-Weight |
| 2018-10-23 | Ripresa | Raymond James | Mkt Perform |
| 2018-07-16 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Downgrade | Jefferies | Buy → Hold |
| 2017-02-09 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Reiterato | Mizuho | Buy |
| 2015-05-07 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Reiterato | Mizuho | Buy |
| 2014-06-12 | Reiterato | Canaccord Genuity | Buy |
| 2014-06-11 | Reiterato | Mizuho | Buy |
| 2012-12-21 | Iniziato | Mizuho | Buy |
| 2012-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Orasure Technologies Inc Borsa (OSUR) Ultime notizie
OraSure (OSUR) CEO gets major stock awards, shares withheld for taxes - Stock Titan
OraSure Technologies, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:OSUR) 2026-03-03 - Seeking Alpha
Healthy Trucking Association Launches Hepatitis C Initiative - Heavy Duty Trucking
OSUR Should I Buy - Intellectia AI
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OraSure Technologies (OSUR) Loss Worsens To US$0.27 EPS And Tests Margin Recovery Narrative - Sahm
OraSure Technologies Q4 Earnings Call Highlights - MarketBeat
OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Highlights - GuruFocus
OraSure signals revenue ramp in H2 2026 with two FDA-submitted diagnostics launches - MSN
Earnings Call Summary | OraSure Technologies(OSUR.US) Q4 2025 Earnings Conference - 富途牛牛
OraSure: Fourth Quarter Financial Results Overview - Bitget
OraSure Technologies Inc reports results for the quarter ended September 30Earnings Summary - TradingView
OraSure closes the book on 'transition year' of 2025 - WFMZ.com
OraSure Technologies (NASDAQ:OSUR) Releases Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Earnings call transcript: OraSure Technologies Q4 2025 earnings fall short of revenue expectations - Investing.com
OraSure: Q4 Earnings Snapshot - Barchart.com
OraSure Technologies (OSUR) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
OraSure Highlights 2025 Results and 2026 Growth Outlook - TipRanks
OraSure Announces Fourth Quarter 2025 Financial Results - The Manila Times
Revenue drops as OraSure (NASDAQ: OSUR) posts deeper 2025 loss - Stock Titan
Tranche Update on OraSure Technologies, Inc.'s Equity Buyback Plan announced on March 24, 2025. - marketscreener.com
OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
OraSure Technologies (OSUR) Expected to Announce Earnings on Wednesday - MarketBeat
Aug Technicals: Can Fulgent Genetics Inc stock outperform in a bear marketQuarterly Investment Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
OraSure’s HIV self-test receives Health Canada license By Investing.com - Investing.com Nigeria
OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
OraSure makes job cuts as it ‘rebalances’ for future growth - Lehigh Valley Business
How sensitive is OraSure Technologies Inc. to inflationJuly 2025 Setups & Verified Chart Pattern Signals - mfd.ru
Will OraSure Technologies Inc. stock benefit from automationJuly 2025 Final Week & Weekly High Potential Alerts - mfd.ru
Oral HIV self-test approved for sale in Canada - CBC
Oral HIV self-test can now be sold in Canada in ‘key’ move - Global News
Canada’s first oral HIV self-test has been approved for sale - The Globe and Mail
OraSure (OSUR) Gains Health Canada Approval for OraQuick HIV Sel - GuruFocus
Orasure to Launch Oraquick?? Hiv Self-Test in Canada - marketscreener.com
OraSure’s HIV self-test receives Health Canada license - Investing.com
OraSure to Launch OraQuick™ HIV Self-Test in Canada - ChartMill
At-home oral HIV self-test approved for sale in Canada - Toronto Sun
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th - The Manila Times
OraSure Technologies, Inc. Schedules Fourth Quarter 2025 Earnings Conference Call for February 25, 2026 - Quiver Quantitative
OraSure trimming global workforce, including here in Lehigh Valley - WFMZ.com
Treasury Yields: How does OraSure Technologies Inc perform in inflationary periodsJuly 2025 Spike Watch & Smart Allocation Stock Reports - baoquankhu1.vn
OraSure Technologies (NASDAQ:OSUR) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Aug Rallies: Should I set a stop loss on PATH2025 Risk Factors & Long Hold Capital Preservation Tips - baoquankhu1.vn
Does OraSure Technologies Inc. have a sustainable dividendEarnings Growth Summary & Long-Term Capital Growth Strategies - mfd.ru
Investment Review: Can OraSure Technologies Inc maintain sales growth2025 Support & Resistance & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Ideas: Is ATHM in a bullish channelEarnings Beat & Detailed Earnings Play Alerts - baoquankhu1.vn
OraSure files for FDA review of molecular self-test & Colli-Pee device - MSN
Risk Analysis: Does OraSure Technologies Inc. have a sustainable dividend2025 Retail Activity & Consistent Income Trade Recommendations - baoquankhu1.vn
Is OraSure Technologies Inc. stock attractive for growth ETFsPortfolio Value Report & Verified Short-Term Plans - bollywoodhelpline.com
Orasure Technologies Inc Azioni (OSUR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.58%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):